Past Updates from the Clinician Registry Listserv
Update Sent November 20, 2006
NOTE: This document is provided for historical purposes only and may not provide our most accurate and up-to-date information. The most current Clinician's information can be found on the Clinician Home Page.
Today's topics include:
COCA Call Replay Information
If you missed our last COCA Conference Call on Infection Control and Pandemic Influenza you can still listen to the replay of the call!The replay number is: 888-568-0013 (available until November 30th).
A link for a downloadable MP3 file of the recording of the call will also be posted to the COCA webpage soon and the transcript will be available in a few weeks. For additional details, please visit the COCA homepage: http://www.bt.cdc.gov/coca/.
Pandemic Influenza
U.S. and Mexico Pledge Increased Cooperation in Pandemic Influenza Preparedness Along Border - DHHS News Release - November 14
The United States and México announced the signing of an agreement to boost cooperation on pandemic influenza preparedness among the six Mexican states and four U.S. states that share the international boundary.
http://www.hhs.gov/news/press/2006pres/20061114.html
Pandemic Planning Update III - November 13
Department of Health and Human Services released Pandemic Planning Update III.
http://www.pandemicflu.gov/plan/pdf/panflureport3.pdf
Avian Influenza
Inexpensive Test Detects H5N1 Infections Quickly and Accurately - NIH News Release - November 14
Scientists from the University of Colorado at Boulder and the Centers for Disease Control and Prevention (CDC) have developed an inexpensive “gene chip” test based on a single influenza virus gene that could allow scientists to quickly identify flu viruses, including avian influenza H5N1.
http://www.nih.gov/news/pr/nov2006/niaid-14.htm
Seasonal Influenza
On November 13, 2006, FDA approved a labeling supplement for Roche Laboratories’ Tamiflu (Oseltamivir Phosphate) to include a precaution about neuropsychiatric events. The revision is based on postmarketing reports (mostly from Japan) of self-injury and delirium with the use of Tamiflu in patients with influenza. The reports were primarily among pediatric patients. The relative contribution of the drug to these events is not known. However, people with the flu, particularly children, may be at an increased risk of self-injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior. A healthcare professional should be contacted immediately if the patient taking Tamiflu shows any signs of unusual behavior. Visit http://www.fda.gov/medwatch/safety/2006/safety06.htm#tamiflu for more information.
http://www.cdc.gov/flu/professionals/treatment/
Weekly Report: Influenza Summary Update - November 17
During week 45 (November 5 – November 11, 2006), a low level of influenza activity was reported in the United States. Eighty-two (4.6%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories were positive for influenza. The proportion of patient visits to sentinel providers for influenza-like illness (ILI) and the proportion of deaths attributed to pneumonia and influenza were below baseline levels. Two states reported regional influenza activity; four states reported local influenza activity; 21 states and the District of Columbia reported sporadic influenza activity; and 23 states and New York City reported no influenza activity.
http://www.cdc.gov/flu/weekly/
Weekly US Map - November 17
http://www.cdc.gov/flu/weekly/usmap.htm
Our Clinician Communication Team is committed to excellence in reporting our weekly updates. Please e-mail coca@cdc.gov should you note any written errors or discrepancies.
If you need to unsubscribe or update your information, please go to our website: http://www.bt.cdc.gov/clinregistry
If you need further information or technical help, please send an e-mail message to: coca@cdc.gov
- Page last updated November 20, 2006
- Content source: CDC Emergency Communication System (ECS), Division of Health Communication and Marketing (DHCM), National Center for Health Marketing (NCHM)
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov
